Boston Research & Management’s Praxair Inc PX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-17,770
Closed -$2.86M 107
2018
Q3
$2.86M Buy
17,770
+100
+0.6% +$16.1K 1.31% 40
2018
Q2
$2.79M Buy
17,670
+300
+2% +$46.4K 1.38% 40
2018
Q1
$2.51M Buy
17,370
+225
+1% +$35K 1.28% 39
2017
Q4
$2.65M Sell
17,145
-475
-3% -$70.5K 1.33% 39
2017
Q3
$2.46M Buy
17,620
+500
+3% +$66.6K 1.26% 43
2017
Q2
$2.27M Hold
17,120
1.23% 43
2017
Q1
$2.03M Buy
17,120
+555
+3% +$65.3K 1.11% 44
2016
Q4
$1.94M Buy
16,565
+140
+0.9% +$16.6K 1.1% 46
2016
Q3
$1.98M Buy
16,425
+175
+1% +$20.7K 1.15% 44
2016
Q2
$1.83M Buy
16,250
+720
+5% +$81.7K 1.11% 46
2016
Q1
$1.78M Buy
15,530
+4,335
+39% +$452K 1.11% 45
2015
Q4
$1.15M Sell
11,195
-1,830
-14% -$200K 0.71% 54
2015
Q3
$1.33M Sell
13,025
-4,885
-27% -$539K 0.87% 50
2015
Q2
$2.14M Buy
+17,910
New +$2.18M 1.36% 41

Other funds holding PX

Boston Research & Management's PX Position: Q4 2018 in Review

Boston Research & Management sold out of Praxair Inc (PX) in Q4 2018, closing a stake of 17,770 shares — an estimated $2.86M sold.

Boston Research & Management first reported a position in PX in Q2 2015 and held it in 14 quarters. The position peaked at $2.86M in Q3 2018. 6 funds tracked by Wall St. Rank hold PX as of Q4 2018.

  • Boston Research & Management reported no remaining Praxair Inc position as of Q4 2018 after selling out during the quarter.
  • Boston Research & Management sold 17,770 Praxair Inc shares in Q4 2018, an estimated $2.86M.
  • Boston Research & Management first reported a position in Praxair Inc in Q2 2015 and held it in 14 quarters.
  • Boston Research & Management's Praxair Inc position peaked at $2.86M in Q3 2018.
  • 6 funds tracked by Wall St. Rank held Praxair Inc as of Q4 2018.

Based on Boston Research & Management's 13F filing for Q4 2018, filed 6 Feb 2019.